Racial and socioeconomic disparities in ocular surface squamous neoplasia: a National Cancer Database analysis

References

• Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94(8):666–668. http://www.ncbi.nlm.nih.gov/pubmed/12152921.
   PubMed Web of Science ®Google Scholar
• Swan J, Breen N. Social inequalities and cancer. JNCI J Natl Cancer Inst. 1999;91(12):1073–1074. doi:10.1093/jnci/91.12.1073.
   Web of Science ®Google Scholar
• Kogevinas M, Pearce N, Susser M, Boffetta P. Social Inequalities and Cancer. France: IARC Lyon; 1997. http://publications.iarc.fr/_publications/media/download/3565/00063107578382cdf8f41bbb857f461ec1b5f431.pdf
   Google Scholar
• Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian SV, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: The public health disparities geocoding project. Am J Epidemiol. 2002;156(5):471–482. doi:10.1093/aje/kwf068.
   PubMed Web of Science ®Google Scholar
• Singh GK, Williams SD, Siahpush M, Mulhollen A. Socioeconomic, Rural-Urban, and racial inequalities in US cancer mortality: part I—all cancers and lung cancer and part II—colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol. 2011;2011:1–27. doi:10.1155/2011/107497.
   Google Scholar
• Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950–2014: over six decades of changing patterns and widening inequalities. J Environ Public Health. 2017;2017:1–19. doi:10.1155/2017/2819372.
   Web of Science ®Google Scholar
• Grossniklaus HE, Green WR, Luckenbach M, Chan CC. Conjunctival lesions in adults. Cornea. 1987;6(2):78–116. doi:10.1097/00003226-198706020-00002.
   PubMed Web of Science ®Google Scholar
• Emmanuel B, Ruder E, Lin S-W, Abnet C, Hollenbeck A, Mbulaiteye S. Incidence of squamous-cell carcinoma of the conjunctiva and other eye cancers in the NIH-AARP diet and health study. Ecancermedicalscience. 2012;6:254. doi:10.3332/ecancer.2012.254.
   PubMedGoogle Scholar
• Shields CL, Demirci H, Karatza E, Shields JA. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology. 2004;111(9):1747–1754. doi:10.1016/j.ophtha.2004.02.013.
   PubMed Web of Science ®Google Scholar
• Sun EC, Fears TR, Goedert JJ. Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(2):73–77. http://www.ncbi.nlm.nih.gov/pubmed/9037556.
   PubMed Web of Science ®Google Scholar
• Mittal R, Rath S, Vemuganti GK. Ocular surface squamous neoplasia – review of etio-pathogenesis and an update on clinico-pathological diagnosis. Saudi J Ophthalmol. 2013;27(3):177–186. doi:10.1016/j.sjopt.2013.07.002.
   PubMedGoogle Scholar
• Lindenmuth KA, Sugar A, Kincaid MC, Nelson CC, Comstock CP. Invasive squamous cell carcinoma of the conjunctiva presenting as necrotizing scleritis with scleral perforation and uveal prolapse. Surv Ophthalmol. 1988;33(1):50–54. doi:10.1016/0039-6257(88)90072-0.
   PubMed Web of Science ®Google Scholar
• Shields CL, Manchandia A, Subbiah R, Eagle RC, Shields JA. Pigmented squamous cell carcinoma in situ of the conjunctiva in 5 cases. Ophthalmology. 2008;115(10):1673–1678. doi:10.1016/j.ophtha.2008.01.020.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhou Z, Xu Y, et al. The clinical value of in vivo confocal microscopy for diagnosis of ocular surface squamous neoplasia. Eye. 2012;26(6):781–787.doi:10.1038/eye.2012.15.
   PubMed Web of Science ®Google Scholar
• Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39(6):429–450. doi:10.1016/S0039-6257(05)80054-2.
   PubMed Web of Science ®Google Scholar
• Basti S, Macsai MS. Ocular surface squamous neoplasia. Cornea. 2003;22(7):687–704. doi:10.1097/00003226-200310000-00015.
   PubMed Web of Science ®Google Scholar
• Carreira H, Coutinho F, Carrilho C, Lunet N. HIV and HPV infections and ocular surface squamous neoplasia: systematic review and meta-analysis. Br J Cancer. 2013;109(7):1981–1988. doi:10.1038/bjc.2013.539.
   PubMed Web of Science ®Google Scholar
• Nagaiah G, Stotler C, Orem J, Mwanda WO, Remick SC. Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa. Curr Opin Oncol. 2010;22(5):437–442. doi:10.1097/CCO.0b013e32833cfcf9.
   PubMed Web of Science ®Google Scholar
• Shields JA, Shields CL. Eyelid, Conjunctival, and Orbital Tumors: An Atlas and Textbook. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 2008.
   Google Scholar
• Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. Arch Ophthalmol (Chicago, Ill 1960). 1997;115(6):808–815. doi:10.1001/archopht.1997.01100150810025.
   PubMedGoogle Scholar
• Tabin G, Levin S, Snibson G, Loughnan M, Taylor H. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology. 1997;104(3):485–492. doi:10.1016/S0161-6420(97)30287-5.
   PubMed Web of Science ®Google Scholar
• Erie JC, Campbell RJ, Liesegang TJ. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology. 1986;93(2):176–183. doi:10.1016/S0161-6420(86)33764-3.
   PubMed Web of Science ®Google Scholar
• Al Bayyat G, Arreaza-Kaufman D, Venkateswaran N, Galor A, Karp CL. Update on pharmacotherapy for ocular surface squamous neoplasia. Eye Vis. 2019;6(1):24. doi:10.1186/s40662-019-0150-5.
   PubMedGoogle Scholar
• Kaliki S, Bejjanki KM, Desai A, Mohamed A. Interferon alfa 2b for ocular surface squamous neoplasia: factors influencing the treatment response. Semin Ophthalmol. 2019;34(7–8):465–472. doi:10.1080/08820538.2019.1648691.
   PubMed Web of Science ®Google Scholar
• Galor A, Karp CL, Chhabra S, Barnes S, Alfonso EC. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Br J Ophthalmol. 2010;94(5):551–554. doi:10.1136/bjo.2008.153197.
   PubMed Web of Science ®Google Scholar
• Adler E, Turner JR, Stone DU. Ocular Surface Squamous Neoplasia. Cornea. 2013;32(12):1558–1561. doi:10.1097/ICO.0b013e3182a6ea6c.
   PubMed Web of Science ®Google Scholar
• Joag MG, Sise A, Murillo JC, et al. Topical 5-fluorouracil 1% as primary treatment for ocular surface squamous neoplasia. Ophthalmology. 2016;123(7):1442–1448.doi:10.1016/j.ophtha.2016.02.034.
   PubMed Web of Science ®Google Scholar
• Shields CL, Demirci H, Marr BP, Masheyekhi A, Materin M, Shields JA. Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva. Arch Ophthalmol (Chicago, Ill 1960). 2005;123(1):109–113. doi:10.1001/archopht.123.1.109.
   PubMedGoogle Scholar
• Chen C, Louis D, Todd T, Mitomycin MJ. C as an adjunct in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol. 2004;88(1):17–18. doi:10.1136/bjo.88.1.17.
   PubMed Web of Science ®Google Scholar
• Kenawy N, Garrick A, Heimann H, Coupland SE, Damato BE. Conjunctival squamous cell neoplasia: the Liverpool ocular oncology centre experience. Graefe’s Arch Clin Exp Ophthalmol. 2015;253(1):143–150. doi:10.1007/s00417-014-2860-7.
   PubMed Web of Science ®Google Scholar
• Moon CS, Nanji AA, Galor A, McCollister KE, Karp CL. Surgical versus medical treatment of ocular surface squamous neoplasia. Ophthalmology. 2016;123(3):497–504. doi:10.1016/j.ophtha.2015.10.043.
   PubMed Web of Science ®Google Scholar
• Ramberg I, Heegaard S, Prause JU, Sjö NC, Toft PB. Squamous cell dysplasia and carcinoma of the conjunctiva. A nationwide, retrospective, epidemiological study of Danish patients. Acta Ophthalmol. 2015;93(7):663–666. doi:10.1111/aos.12743.
   PubMed Web of Science ®Google Scholar
• Mercado CL, Pole C, Wong J, et al. Surgical versus medical treatment for ocular surface squamous neoplasia: a quality of life comparison. Ocul Surf. 2019;17(1):60–63.doi:10.1016/j.jtos.2018.09.001.
   PubMed Web of Science ®Google Scholar
• Gagliardi AR, Dobrow MJ, Wright FC. How can we improve cancer care? A review of interprofessional collaboration models and their use in clinical management. Surg Oncol. 2011;20(3):146–154. doi:10.1016/j.suronc.2011.06.004.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Vahabzadeh A, Magruder K. Screening for distress and depression in cancer settings: 10 lessons from 40 years of primary-care research. Psychooncology. 2011;20(6):572–584. doi:10.1002/pon.1943.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The national cancer data base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3):683–690. doi:10.1245/s10434-007-9747-3.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8.
   PubMedGoogle Scholar
• Tunc M, Char DH, Crawford B, Miller T. Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. Br J Ophthalmol. 1999;83(1):98–103. doi:10.1136/bjo.83.1.98.
   PubMed Web of Science ®Google Scholar
• Cicinelli MV, Marchese A, Bandello F, Modorati G. Clinical management of ocular surface squamous neoplasia: a review of the current evidence. Ophthalmol Ther. 2018;7(2):247–262. doi:10.1007/s40123-018-0140-z.
   PubMed Web of Science ®Google Scholar
• Karami S, Young HA, Henson DE. Earlier age at diagnosis: another dimension in cancer disparity? Cancer Detect Prev. 2007;31(1):29–34. doi:10.1016/j.cdp.2006.11.004.
   PubMedGoogle Scholar
• Beral V, Newton R. Overview of the epidemiology of immunodeficiency-associated cancers. JNCI Monogr. 1998;1998(23):1–6. doi:10.1093/oxfordjournals.jncimonographs.a024164.
   Google Scholar
• Newton ER, Beral V, Weiss RA. Infections and Human Cancer: Cancer Surveys. London, United Kingdom: BMJ-Britis; 1999.
   Google Scholar
• Newton R, Ziegler J, Ateenyi-Agaba C, et al. The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer. 2002;87(3):301–308.doi:10.1038/sj.bjc.6600451.
   PubMed Web of Science ®Google Scholar
• Simbiri KO, Murakami M, Feldman M, et al. Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients. Infect Agent Cancer. 2010;5(1):6.doi:10.1186/1750-9378-5-6.
   PubMedGoogle Scholar
• Makupa II, Swai B, Makupa WU, White VA, Lewallen S. Clinical factors associated with malignancy and HIV status in patients with ocular surface squamous neoplasia at Kilimanjaro Christian Medical Centre, Tanzania. Br J Ophthalmol. 2012;96(4):482–484. doi:10.1136/bjophthalmol-2011-300485.
   PubMed Web of Science ®Google Scholar
• Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16(5):442–449. doi:10.2174/1573399815666191024085838.
   PubMed Web of Science ®Google Scholar
• Afshar S, Roderick PJ, Kowal P, Dimitrov BD, Hill AG. Multimorbidity and the inequalities of global ageing: a cross-sectional study of 28 countries using the World Health Surveys. BMC Public Health. 2015;15(1):776. doi:10.1186/s12889-015-2008-7.
   PubMed Web of Science ®Google Scholar
• Schiøtz ML, Stockmarr A, Høst D, Glümer C, Frølich A. Social disparities in the prevalence of multimorbidity – a register-based population study. BMC Public Health. 2017;17(1):422. doi:10.1186/s12889-017-4314-8.
   PubMedGoogle Scholar
• Puent BD, Klein BEK, Klein R, Cruickshanks KJ, Nondahl DM. Factors Related to Vision Care in an Older Adult Cohort. Optom Vis Sci. 2005;82(7):612–616. doi:10.1097/01.opx.0000171334.54708.89.
   PubMed Web of Science ®Google Scholar
• Lurie N, Kamberg CJ, Brook RH, Keeler EB, Newhouse JP. How free care improved vision in the health insurance experiment. Am J Public Health. 1989;79(5):640–642. doi:10.2105/AJPH.79.5.640.
   PubMed Web of Science ®Google Scholar
• Lee DJ, Lam BL, Arora S, et al. Reported eye care utilization and health insurance status among US adults. Arch Ophthalmol (Chicago, Ill 1960). 2009;127(3):303–310.doi:10.1001/archophthalmol.2008.567.
   PubMedGoogle Scholar
• Morales LS, Varma R, Paz SH, et al. Self-reported use of eye care among latinos. Ophthalmology. 2010;117(2):207–215.e1.doi:10.1016/j.ophtha.2009.07.015.
   PubMed Web of Science ®Google Scholar
• Smith DA, Akira A, Hudson K. et al. The effect of health insurance coverage and the doctor-patient relationship on health care utilization in high poverty neighborhoods. Prev Med Rep. 2017;7:158–161. doi:10.1016/j.pmedr.2017.06.002.
   PubMedGoogle Scholar
• DeNavas-Walt C, Proctor BD, Smith JC. Income, Poverty, and Health Insurance Coverage in the United States: 2012. 2012. US Department of Commerce, US Census Bureau. https://www.census.gov/prod/2013pubs/p60-245.pdf
   Google Scholar
• Do DP, Frank R, Iceland J. Black-white metropolitan segregation and self-rated health: investigating the role of neighborhood poverty. Soc Sci Med. 2017;187:85–92. doi:10.1016/j.socscimed.2017.06.010.
   PubMed Web of Science ®Google Scholar
• Proser M, Shin P. The role of community health centers in responding to disparities in visual health. Optom - J Am Optom Assoc. 2008;79(10):564–575. doi:10.1016/j.optm.2008.04.101.
   PubMedGoogle Scholar
• Reducing LB. Disparities in pediatric vision care utilization by strategically addressing access. JAMA Ophthalmol. 2019;137(2):127. doi:10.1001/jamaophthalmol.2018.5939.
   PubMed Web of Science ®Google Scholar
• Campbell JP, Mathenge C, Cherwek H, et al. Artificial intelligence to reduce ocular health disparities: moving from concept to implementation. Transl Vis Sci Technol. 2021;10(3):19.doi:10.1167/tvst.10.3.19.
   PubMed Web of Science ®Google Scholar
• Leese GP, Boyle P, Feng Z, Emslie-Smith A, Ellis JD. Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care. 2008;31(11):2131–2135. doi:10.2337/dc08-1098.
   PubMed Web of Science ®Google Scholar
• Hoffman-Goetz L, Breen NL, Meer H. The impact of social class on the use of cancer screening within three racial/ethnic groups in the United States. Ethn Dis. 1998;8(1):43–51. http://www.ncbi.nlm.nih.gov/pubmed/9595247.
   PubMedGoogle Scholar
• Ndegwa L, Karimurio J, Okelo R, Adala H. Barriers to utilisation of eye care services in Kibera slums of Nairobi. East Afr Med J. 2006;82:10. doi:10.4314/eamj.v82i10.9347.
   Google Scholar
• Busolo DS, Woodgate RL. Cancer prevention in Africa: a review of the literature. Glob Health Promot. 2015;22(2):31–39. doi:10.1177/1757975914537094.
   PubMed Web of Science ®Google Scholar
• Gichuhi S, Macharia E, Kabiru J, et al. Clinical presentation of ocular surface squamous neoplasia in Kenya. JAMA Ophthalmol. 2015;133(11):1305.doi:10.1001/jamaophthalmol.2015.3335.
   PubMed Web of Science ®Google Scholar
• Gichuhi S, Macharia E, Kabiru J, et al. Risk factors for ocular surface squamous neoplasia in Kenya: a case-control study. Trop Med Int Heal. 2016;21(12):1522–1530.doi:10.1111/tmi.12792.
   PubMed Web of Science ®Google Scholar
• Palma DA. National cancer data base: an important research tool, but not population-based. J Clin Oncol.2017;35(5):571. doi:10.1200/JCO.2016.69.2855.
   PubMed Web of Science ®Google Scholar